Treatment of leptomeningeal spread of NSCLC: a continuing challenge (Q48427334)

11 February 2018

title

Treatment of leptomeningeal spread of NSCLC: a continuing challenge (English)

1 reference

11 February 2018

author name string

Seema Nagpal

series ordinal

1

1 reference

11 February 2018

Jonathan Riess

series ordinal

2

1 reference

11 February 2018

Heather Wakelee

series ordinal

3

1 reference

11 February 2018

publication date

1 December 2012

1 reference

11 February 2018

Current Treatment Options in Oncology

published in

1 reference

11 February 2018

volume

13

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

491-504

1 reference

11 February 2018

Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Use of magnetic resonance imaging to detect neoplastic meningitis: limited use in leukemia and lymphoma but convincing results in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Remission induction of meningeal leukemia with high-dose intravenous methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Central nervous system pharmacokinetics of high-dose cytosine arabinoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

CSF concentration of the anaplastic lymphoma kinase inhibitor crizotinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Effectiveness and limitation of gamma knife radiosurgery for relapsed central nervous system lymphoma: a retrospective analysis in one institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Safety and pharmacokinetics of intrathecal administration of pemetrexed in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Response of neoplastic meningitis from solid tumors to oral capecitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Dramatic response with capecitabine after cranial radiation to the brain parenchymal and leptomeningeal metastases from lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Intrathecal mafosfamide: a preclinical pharmacology and phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11864-012-0206-4

Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status

21 January 2018

1 reference

12 December 2020

Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small cell lung cancer

1 reference

12 December 2020

Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis

1 reference

12 December 2020

Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma

1 reference

12 December 2020

Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial

1 reference

12 December 2020

Leptomeningeal metastases

1 reference

12 December 2020

High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?

1 reference

12 December 2020

"Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer.

1 reference

12 December 2020

Pharmacokinetics of methotrexate following intravenous and intraventricular administration in acute lymphocytic leukemia and non-Hodgkin's lymphoma

1 reference

12 December 2020

A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors

1 reference

12 December 2020

CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases

1 reference

12 December 2020

Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results

1 reference

12 December 2020

"Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms

1 reference

12 December 2020

Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates

1 reference

12 December 2020

Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)

1 reference

12 December 2020

10.1007/S11864-012-0206-4

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018